Literature DB >> 27195001

Brain Perfusion in Corticobasal Syndrome with Progressive Aphasia.

Yoshitake Abe1, Noriyuki Kimura1, Megumi Goto1, Yasuhiro Aso1, Etsuro Matsubara1.   

Abstract

BACKGROUND: Brain perfusion may differ between patients with corticobasal syndrome (CBS) with and without aphasia.
METHODS: Twenty-six (9 males and 17 females; mean age 76 ± 5.3 years) patients with CBS were enrolled in the study. Brain MRI and single-photon emission computed tomography were performed in all subjects. Language was evaluated using the Standard Language Test of Aphasia. The patients were divided into two subgroups according to the presence or absence of progressive aphasia. Differences in the regional cerebral blood flow (rCBF) between the two groups were detected based on voxel-by-voxel group analysis using Statistical Parametric Mapping 8.
RESULTS: All patients exhibited asymmetric motor symptoms and signs, including limb apraxia, bradykinesia, and akinetic rigidity. Of 26 patients, 9 had a clinically obvious language disturbance, characterized as nonfluent aphasia. Almost all CBS patients with aphasia exhibited cortical atrophy predominantly in the left frontal and temporal lobes with widening of the Sylvian fissure on MRI. The rCBF in the left middle frontal gyrus differed significantly between CBS patients with and without aphasia.
CONCLUSION: CBS patients with aphasia exhibit motor symptoms predominantly on the right side and cortical atrophy mainly in the left perisylvian cortices. In particular, left frontal dysfunction might be related to nonfluent aphasia in CBS.

Entities:  

Keywords:  Aphasia; Brain perfusion SPECT; Corticobasal syndrome; Statistical Parametric Mapping 8

Year:  2016        PMID: 27195001      PMCID: PMC4868931          DOI: 10.1159/000443329

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Dis Extra        ISSN: 1664-5464


Introduction

Corticobasal degeneration (CBD) is a neurodegenerative disorder characterized by progressive asymmetric rigidity and apraxia with other variable findings, including cortical sensory loss, alien limb phenomena, myoclonus, and dystonia [1]. Patients with pathologically confirmed CBD often present with various cognitive deficits during the course of the disease [2,3,4]. Pathologic heterogeneity is also reported in clinically diagnosed CBD patients [5,6,7]. Therefore, recent studies use the term corticobasal syndrome (CBS) for the clinical syndrome, and the term CBD for the histopathologic disorder [7]. The cognitive deficits of CBS include language disturbances and frontotemporal dysfunction. Language disturbance is particularly focused on as the diagnostic criterion for CBS because over one third of all CBS patients have aphasia, characterized as the nonfluent type [8,9,10]. A few studies have evaluated the relationship between cognitive deficits and MRI findings in CBD [11,12,13]. Frattali et al. [11] suggest that aphasia in CBD is associated primarily with left frontal and parietal cortical damage, and subcortical white matter and corpus callosum abnormalities. Brain perfusion single-photon emission computed tomography (SPECT) imaging is widely available and provides an indirect marker of neuronal function. Characteristic perfusion SPECT findings of CBS are the presence of asymmetric perfusion and a decreased regional cerebral blood flow (rCBF) in the frontoparietal cortices, basal ganglia, thalamus, pons, and cerebellum [14,15]. To our knowledge, there are few studies of the relationship between language disturbances and perfusion SPECT in CBS. It is important to confirm the SPECT patterns of CBS with and without aphasia for an accurate diagnosis and to gain a better understanding of the distribution of pathologic changes in CBS. The aim of the present study was to elucidate the differences in the SPECT pattern of CBS patients with and without aphasia, using the Statistical Parametric Mapping 8 (SPM8) program.

Materials and Methods

Subjects

We consecutively enrolled 26 patients with CBS (9 males and 17 females; mean age 76 ± 5.3 years) who were admitted to the Department of Neurology, Oita University Hospital, between 2006 and 2014. CBS was diagnosed according to the diagnostic criteria proposed by Mathew et al. [9]. All patients satisfied the clinical criteria for possible CBD. Mean (±SD) disease duration was 2.3 ± 1.2 years, ranging from 1 to 5 years. All patients were right-handed and underwent a clinical evaluation that included past medical history as well as physical and neurologic examination. Information regarding age, sex, and disease duration was extracted from the medical records. Language was evaluated using the Standard Language Test of Aphasia [16]. The patients were divided into two subgroups according to the presence or absence of aphasia. Brain MRI and brain perfusion SPECT were performed for diagnosis. All patients were examined using T1-weighted, T2-weighted, and fluid-attenuated inversion recovery images on a 1.5-tesla scanner (Excelart Vantage; Toshiba Medical System Corp., Tokyo, Japan). Axial and coronal MRIs were obtained and retrospectively reviewed by two registered neurologists blinded to the medical information and used for diagnosis of CBS. Brain atrophy and abnormal signal intensity were examined visually and qualitatively in the cerebral cortex, white matter, and basal ganglia. In case of disagreement, they reviewed the images again together to reach a consensus. We also studied 26 age- and sex-matched control subjects (8 males and 18 females; mean age 76.6 ± 5.8 years) who had no neurologic disorders or cognitive impairment for a voxel-by-voxel group analysis using SPM8. Between-group comparisons of CBS patients with and without aphasia and controls were performed with the χ2 test for sex distribution and a Kruskal-Wallis test, followed by a Mann-Whitney U test for age at examination and mean global CBF. The comparison of disease duration was performed with a Mann-Whitney U test between CBS patients with and without aphasia. A p value <0.05 was considered statistically significant.

Brain SPECT Imaging

The patients were asked to assume a comfortable supine position with the eyes closed in a quiet surrounding. After intravenous injection of 99mTc ethyl cysteinate dimer (600 MBq; FUJIFILM RI Pharma Co., Ltd., Chiba, Japan), its passage to the brain was monitored using a rectangular large-field gamma camera (E. Cam Signature; Toshiba Medical System Corp., Tochigi, Japan). The Patlak plot method was used to measure the mean global CBF on 99mTc ethyl cysteinate dimer cerebral blood perfusion SPECT [17]. Data comprising a sequence of 120 frames were acquired at a rate of 1 Hz with a 128 × 128 matrix. Ten minutes after the angiography, SPECT images were obtained using a rotating dual-head gamma camera equipped with low-energy, high-resolution, and parallel-hole collimators. Energy windows were set at 140 keV ± 20%, and 90 views were obtained throughout 360° of rotation (128 × 128 matrix, 1.95 mm/pixel), with an acquisition time of 140 s/cycle repeated 6 times. Data were processed using a GMS-7700A/EI (Toshiba Medical System Corp.). All images were reconstructed using a ramp-filtered back projection and then three-dimensionally smoothed with a Butterworth filter (order 8, cutoff 0.25 cycles/pixel). The reconstructed images were corrected for gamma ray attenuation using the Chang method (μ = 0.09).

SPECT Image Analysis Using SPM8

A voxel-by-voxel group study was performed using SPM8 (Wellcome Department of Cognitive Neurology, University College, London, UK), running on MATLAB version R2009b (The MathWorks, Inc., Natick, Mass., USA). The images were initially converted from DICOM files to the analysis format using MRIcro and transferred to SPM8. The mean pixel intensity across all slices of the imaging volume was calculated. The pixel threshold was set to 80% of the whole-brain mean to eliminate background noise and partial volume effects at the edge of the brain. The data were standardized with the Montreal Neurological Institute atlas using a 12-parameter affine transformation, followed by nonlinear transformations and a trilinear interpolation. The final image format was 16 bit, with a size of 79 × 95 × 69 voxels and a voxel size of 2 × 2 × 2 mm. The standardized data were smoothed by a Gaussian filter (full width at half maximum: 12 mm). Regional CBF differences were assessed as an intergroup comparison using the ‘compare-populations: 1 scan/subject (two-sample t test)’. Each individual global count was normalized by proportional scaling. The resulting set of values for each comparison constituted a statistical parametric map of the t statistic SPM {t}. The SPM {t} maps were then transformed to the unit of normal distribution (SPM {z}). The SPM {t} maps were initially obtained at a height threshold of p < 0.001 (uncorrected), with an extent threshold of 50 voxels. Montreal Neurological Institute coordinates were finally converted to Talairach brain coordinates.

Statement of Ethics

Fully informed consent was obtained, and all patients and controls agreed to participate in this study.

Results

Table 1 summarizes the clinical and demographic characteristics of CBS patients with and without aphasia. Of 26 patients, 9 exhibited clinically obvious language disturbances, such as speech hesitancy, distortions, phonemic errors, and handwriting difficulty. Comprehension and object knowledge were relatively preserved. These language disturbances are characterized as nonfluent aphasia. The subgroups did not significantly differ in age at examination, sex distribution, or disease duration. Although the mean global CBF value tended to be lower in the CBS-with-aphasia group than in the CBS-without-aphasia group, the difference was not statistically significant (p < 0.06). All patients exhibited asymmetric motor symptoms and signs, including limb apraxia, bradykinesia, and akinetic rigidity (table 2). Levodopa treatment was not effective for the parkinsonian symptoms. Of the total of 26 patients, 17 exhibited predominantly right-sided symptoms, and the remaining 9 patients exhibited predominantly left-sided symptoms. Moreover, 8 of the 9 CBS patients with aphasia exhibited predominantly right-sided motor symptoms. Brain MRI in the CBS patients showed bilateral, usually asymmetric, cortical atrophy, mainly in the frontal and parietal cortices. In some patients, the lesions extended to the temporal or occipital cortices. Asymmetric cortical atrophy was more severe on the side contralateral to the clinically more affected side in 24 patients. The atrophy was equivalent in both hemispheres in the remaining 2 patients. Almost all CBS patients with aphasia had cortical atrophy predominantly in the left frontal and temporal lobes adjacent to the Sylvian fissure as well as in the parietal lobe. There was no abnormal signal intensity in the cortex, white matter, and basal ganglia. Figure 1 shows the comparison of the absolute rCBF between CBS patients with and without aphasia and controls using SPM8. SPM8 analysis revealed asymmetric perfusion and a decreased rCBF predominantly in the left cerebral hemisphere in both CBS groups compared to controls. The CBS-with-aphasia group had a significantly decreased rCBF in the insula, superior temporal gyrus, parahippocampal gyrus, precuneus, and middle occipital gyrus of the left hemisphere and in the posterior cingulate gyrus, uncus, cerebellum, and thalamus of the right hemisphere as well as the bilateral cingulate gyri, compared to controls (fig. 1a, table 3). CBS patients without aphasia had a significantly decreased rCBF in the inferior frontal gyrus and parahippocampal gyrus of the left hemisphere and the superior frontal gyrus, insula, and cuneus of the right hemisphere, as well as the bilateral cingulate gyrus and cerebellum, compared to controls (fig. 1b, table 3). Moreover, a significant difference in the rCBF in the left middle frontal gyrus was detected between CBS patients with and without aphasia (fig. 1c, table 3).
Table 1

Summary of the clinical and demographic characteristics of patients with CBS

CBS with aphasia (n = 9)CBS without aphasia (n = 17)Controls (n = 26)p
Age, years75.9 ± 5.776.1 ± 5.376.6 ± 5.80.98
Sex, M/F3/66/118/180.988
Disease duration, years2.4 ± 1.32.2 ± 1.10.71
CBF, ml/100 g/min36.0 ± 2.638.4 ± 3.740.8 ± 4.40.007

Values are expressed as means ± SD or numbers. p < 0.05 was considered statistically significant.

Table 2

Summary of the motor impairment and brain MRI findings in CBS patients with and without aphasia

PatientDuration, yearsAphasiaMotor impairment
Brain atrophy on MRI
sideextrapyramidalapraxiasidelocation
11NFR++LF, T, P
24NFR++LF, P
35NFR++LF, T, P
43NFR++LF, T, P
52NFR++LF, T, P
61.5NFR++LF, P, O
71.5NFR++LF, T, P
82NFL+RF, T, P
92NFR+LF, P
101.3R++LF, P
112L++BF, P
121.3R++LF, P
133L++RP
143.5L+RP
153L++RF, T, P
162L++RF, T, P
175R+LF, T, P, O
182R+LF, T, P
191L+BF, P
203L+RF, P
213R++LF, P
222.5R++LF, T, P
231L++RF, P
242R++LF, T, P
251R++LF, T, P
261R++LF, T, P

NF = Nonfluent aphasia; side = more affected side; extrapyramidal = extrapyramidal signs; R = right; L = left; B = bilateral; F = frontal lobe; T = temporal lobe; P = parietal lobe; O = occipital lobe.

Fig. 1

SPM brain map of the group comparison. a Group comparison between the CBS-with-aphasia group and controls. Cerebral perfusion was significantly decreased mainly in the left frontal, temporal, and occipital cortices adjacent to the Sylvian fissure in CBS patients with aphasia. b Group comparison between the CBS-without-aphasia group and controls. Cerebral perfusion was significantly decreased mainly in the left frontal, temporal, and occipital cortices, as well as the cerebellum and pons in CBS patients without aphasia. c Group comparison between CBS patients with and without aphasia. Cerebral perfusion was significantly decreased in the left middle frontal gyrus in CBS patients with aphasia.

Table 3

Locations and peaks of significantly decreased rCBF in CBS patients with and without aphasia as well as controls

Voxel level {Z}Voxel p (unc.)Talairach coordinates
Region
xyz
CBS with aphasia vs. controls5.610.000–47.5213.661.16L insula
5.400.000–41.58–0.84–16.78L superior temporal gyrus
4.980.000–37.62–22.68–25.78L parahippocampal gyrus
3.790.0007.92−41.4326.03R posterior cingulate gyrus
3.650.00013.86−25.4734.44R cingulate gyrus
3.670.00029.70−17.01−29.43R uncus
3.540.000−11.88−6.0035.31L cingulate gyrus
3.390.00031.68−36.56−31.81R cerebellum
3.330.0003.96−28.973.29R thalamus
3.330.000−9.90−51.9030.23L precuneus
3.220.001−33.66−80.5520.61L middle occipital gyrus

CBS without aphasia vs. controls4.360.00017.8229.7050.10R superior frontal gyrus
3.950.00013.86−21.6034.24R cingulate gyrus
3.900.0000.00−34.12−21.84L cerebellum
3.180.0010.00−18.87−27.65Pons
3.780.000−57.4218.2715.67L inferior frontal gyrus
3.690.000−35.64−26.45−23.91L parahippocampal gyrus
3.650.000−15.84−21.5036.08L cingulate gyrus
3.550.00043.56−7.0115.09R insula
3.350.0001.98−70.7721.97R cuneus
3.310.00035.64−34.37−26.88R cerebellum

CBS with aphasia vs. CBS without aphasia3.250.001−37.6245.5817.98L middle frontal gyrus

unc. = Uncorrected; R = right; L = left.

Discussion

The present study examined the differences in the rCBF between CBS patients with and without aphasia using the SPM8 program. Compared with controls, CBS patients with and without aphasia showed asymmetric perfusion and a decreased rCBF in the extended cerebral cortex, cerebellum, and brainstem regions. The hypoperfusion area in CBS patients with aphasia was more severe and extensive in the left cerebral cortex than that in CBS patients without aphasia. Moreover, direct comparison between CBS patients with and without aphasia revealed a significant difference in the rCBF in the left frontal cortex. Most CBS patients present with cognitive impairment, including language disturbances, during the course of the disease or even at onset [6,7,8,9]. In the present study, all patients exhibited asymmetric extrapyramidal signs and/or apraxia, and 9 of 26 patients (34.6%) had a language disturbance characterized as nonfluent aphasia. The mean disease duration in our patients upon admission to our hospital was 2.3 ± 1.2 years. These findings reconfirmed that aphasia, particularly the nonfluent type, is more frequent in CBS patients than previously considered and a prominent characteristic. Moreover, 8 of 9 CBS patients with aphasia exhibited predominantly right-sided motor symptoms. A previous study of CBD with aphasia showed predominant motor impairment on the right side in 4 of 8 patients. In the other 4 patients, however, bilateral involvement was evidenced by clinical and MRI findings [11]. Therefore, language disturbances in CBS patients tend to be associated with involvement of the left hemisphere. Characteristic MRI findings of patients with CBS included asymmetric cortical atrophy in the frontal and parietal lobes and basal ganglia [12,13]. The cortical atrophy in these regions was more severe on the side contralateral to the clinically more affected side. Similarly, most of our CBS patients had asymmetric cortical atrophy mainly in the frontal, temporal, and parietal lobes on the side contralateral to the clinically more affected side, whereas 2 patients showed equivalent atrophy in both hemispheres. Moreover, CBS patients with aphasia had cortical atrophy mainly in the left frontal, temporal, and parietal cortices, and only 1 patient had cortical atrophy bilaterally but predominantly in the right hemisphere. These results are consistent with those of a previous study, suggesting a relationship between aphasia and left frontal and parietal cortical involvement in CBD [3,10,11,13]. Characteristic perfusion SPECT findings of CBS are the presence of asymmetric perfusion and a decreased rCBF in the frontoparietal cortices, basal ganglia, thalamus, pons, and cerebellum [14,15]. There are, however, few studies of the relationship between language disturbances and perfusion SPECT in CBS. A single case report showed hypoperfusion in the frontal and temporal cortices, the insula, and the parietal lobe, including the parietal lobules and precuneus, in CBS patients with aphasia [18]. In the present study, we used the absolute rCBF data to evaluate cerebral perfusion using SPM8 analysis according to a previous study, indicating that the adjusted rCBF data may not be suitable for analyzing the rCBF in CBS [12]. SPM8 analysis revealed asymmetric perfusion and a decreased rCBF predominantly in the left cerebral hemisphere, including the frontal, temporal, and occipital cortices, and the thalamus, cerebellum, and pons in patients with CBS with or without aphasia compared to controls. This predominance of brain dysfunction may account for the high frequency of patients with a clinically more affected right side. These findings are consistent with the characteristic SPECT pattern of CBS. Moreover, CBS patients with aphasia showed more severe and extended hypoperfusion, mainly in the left frontal and temporal cortices adjacent to the Sylvian fissure. A previous positron emission tomography study suggested that non-fluent aphasia was associated with the anterior perisylvian region, whereas others described that the language function, particularly phonologic processing, is related to the inferior frontal, superior temporal, and supramarginal gyri, as well as the anterior insula of the left hemisphere [10,17,19]. In the present SPECT study, the rCBF in CBS patients with aphasia was significantly decreased in the left middle frontal gyrus compared to that in CBS patients without aphasia, despite the lack of a significant difference in disease duration and global cerebral perfusion. These findings therefore suggest that more extensive brain dysfunction, particularly in left frontal regions, might be related to nonfluent aphasia in CBS. The present study has several limitations. First, patients were diagnosed based solely on clinical signs and symptoms without pathologic confirmation. Second, the distinct SPECT patterns in CBS patients with and without aphasia must be considered preliminary because of the relatively small number of CBS patients with aphasia. Further studies with larger samples are needed to confirm our results. In conclusion, nonfluent aphasia in patients with CBS is more common than previously considered and an important finding for the diagnosis of CBS. CBS patients with aphasia exhibited predominantly right-sided motor symptoms and cortical atrophy mainly in the left perisylvian cortices. In particular, the left frontal dysfunction might be related to nonfluent aphasia in patients with CBS.

Disclosure Statement

Yoshitake Abe, Noriyuki Kimura, Megumi Goto, Yasuhiro Aso, and Etsuro Matsubara declare that they have no conflicts of interest to declare.
  19 in total

1.  Clinicopathological correlations in corticobasal degeneration.

Authors:  Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

2.  PET studies of phonetic processing of speech: review, replication, and reanalysis.

Authors:  R J Zatorre; E Meyer; A Gjedde; A C Evans
Journal:  Cereb Cortex       Date:  1996 Jan-Feb       Impact factor: 5.357

3.  Corticobasal degeneration: neuropathologic and clinical heterogeneity.

Authors:  J A Schneider; R L Watts; M Gearing; R P Brewer; S S Mirra
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

4.  Corticobasal degeneration and progressive aphasia.

Authors:  Paul McMonagle; Mervin Blair; Andrew Kertesz
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 5.  The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study.

Authors:  Bradley F Boeve
Journal:  J Mol Neurosci       Date:  2011-08-19       Impact factor: 3.444

6.  Language disturbances in corticobasal degeneration.

Authors:  C M Frattali; J Grafman; N Patronas; F Makhlouf; I Litvan
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

7.  From primary progressive aphasia to corticobasal syndrome: two clinical and rCBF functional reports.

Authors:  F Caso; F Onofrio; M Falautano; P Todeschini; R Migliaccio; G Comi; D Perani; G Magnani
Journal:  Neurocase       Date:  2012-04-18       Impact factor: 0.881

8.  Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping.

Authors:  A K M Moinul Hossain; Yuji Murata; Lin Zhang; Shin-ichi Taura; Yukinobu Saitoh; Hidehiro Mizusawa; Kenji Oda; Eisuke Matsushima; Yoshiro Okubo; Hitoshi Shibuya
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

9.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

10.  Corticobasal degeneration presenting with progressive conduction aphasia.

Authors:  Noriyuki Kimura; Toshihide Kumamoto; Takuya Hanaoka; Yusuke Hazama; Kenichiro Nakamura; Ryuki Arakawa
Journal:  J Neurol Sci       Date:  2008-01-29       Impact factor: 3.181

View more
  2 in total

1.  Language in corticobasal syndrome: a systematic review.

Authors:  Isabel Junqueira de Almeida; Marcela Lima Silagi; Jacy Bezerra Parmera; Sonia Maria Dozzi Brucki; Eliane Schochat
Journal:  Dement Neuropsychol       Date:  2021 Jan-Mar

Review 2.  Neuropsychiatric disturbances in atypical parkinsonian disorders.

Authors:  Daniele Belvisi; Isabella Berardelli; Antonio Suppa; Andrea Fabbrini; Massimo Pasquini; Maurizio Pompili; Giovanni Fabbrini
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.